Literature DB >> 2575263

The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985.

R G Watson1, C F Johnston, M M O'Hare, J R Anderson, B G Wilson, J S Collins, J M Sloan, K D Buchanan.   

Abstract

The reported incidence of gastrointestinal endocrine tumours is variable. In Northern Ireland circumstances allowing such an assessment are favourable with a central diagnostic laboratory and register established to collect data on tumours from a well-defined population of 1.5 million people. From 1970 to 1985, 368 cases were recorded of which 85 per cent were carcinoid tumours. The annual incidence of carcinoid tumours was 1.3 per 100,000 of the population and the majority occurred in the appendix (61 per cent). No patients presented with the carcinoid syndrome. The annual incidence for other tumours was 0.12 per 100,000 for insulinomas; islet cell tumours of unknown type 0.07; Zollinger-Ellison syndrome 0.05; and multiple endocrine neoplasia (MEN) 0.05. There were two cases of VIPoma, one glucagonoma, one neurotensinoma and one tumour producing ACTH. It is possible that some tumours are more uncommon than others because of difficulty in diagnosis.

Entities:  

Mesh:

Year:  1989        PMID: 2575263

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  18 in total

Review 1.  Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.

Authors:  C Mao; A el Attar; D R Domenico; K Kim; J M Howard
Journal:  Int J Pancreatol       Date:  1998-04

2.  Distribution of napin and cruciferin in developing rape seed embryos.

Authors:  A S Höglund; J Rödin; E Larsson; L Rask
Journal:  Plant Physiol       Date:  1992-02       Impact factor: 8.340

Review 3.  The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.

Authors:  W P Tormey; R J FitzGerald
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

4.  Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Authors:  Allen B Choi; Jessica E Maxwell; Kendall J Keck; Andrew J Bellizzi; Joseph S Dillon; Thomas M OʼDorisio; James R Howe
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

Review 5.  Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.

Authors:  S F Leavey; H Holloway; M G Courtney; B E Lane; D Royston; K D Buchanan; J F Fielding
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

Review 6.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

7.  Incidence and management of malignant digestive endocrine tumours in a well defined French population.

Authors:  C Lepage; A M Bouvier; J M Phelip; C Hatem; C Vernet; J Faivre
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

8.  Neoplasms Causing Nonhyperinsulinemic Hypoglycemia.

Authors:  Ricardo V. Lloyd; Lori A. Erickson; Antonio G. Nascimento; Günter Klöppel
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

9.  Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Authors:  T R Halfdanarson; K G Rabe; J Rubin; G M Petersen
Journal:  Ann Oncol       Date:  2008-05-30       Impact factor: 32.976

10.  Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

Authors:  G B Turner; B T Johnston; D R McCance; A McGinty; R G P Watson; C C Patterson; J E S Ardill
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.